Brown, Lisle/Cummings’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
Brown, Lisle/Cummings's MDT Position: Q2 2026 in Review
Brown, Lisle/Cummings reduced its Medtronic (MDT) stake by 12% in Q2 2026, selling an estimated $13.2K and leaving 1,165 shares worth $91.1K. The position accounts for 0.02% of the portfolio, ranked #315.
Brown, Lisle/Cummings first reported a position in MDT in Q4 2021 and has held it in 19 quarters since. The position peaked at $146K in Q1 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Brown, Lisle/Cummings held 1,165 shares of Medtronic worth $91.1K as of Q2 2026.
- Brown, Lisle/Cummings sold 164 Medtronic shares in Q2 2026, an estimated $13.2K.
- Medtronic made up 0.02% of Brown, Lisle/Cummings's portfolio in Q2 2026, its #315 holding.
- Brown, Lisle/Cummings first reported a position in Medtronic in Q4 2021 and has held it in 19 quarters since.
- Brown, Lisle/Cummings's Medtronic position peaked at $146K in Q1 2025.
- 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Brown, Lisle/Cummings's 13F filing for Q2 2026, filed 2 Sep 2026.